Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017150686) COMPOSITION USED TO IMPROVE SYMPTOMS OF AUTISM SPECTRUM DISORDER, AND METHOD USING SAME FOR IMPROVING SYMPTOMS OF AUTISM SPECTRUM DISORDER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/150686 International Application No.: PCT/JP2017/008355
Publication Date: 08.09.2017 International Filing Date: 02.03.2017
IPC:
A61K 31/44 (2006.01) ,A23L 33/15 (2016.01) ,A61K 31/4545 (2006.01) ,A61K 31/51 (2006.01) ,A61P 25/00 (2006.01) ,A61P 43/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
[IPC code unknown for A23L 33/15]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506
not condensed and containing further heterocyclic rings
51
Thiamines, e.g. vitamin B1
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
Applicants:
国立大学法人東北大学 TOHOKU UNIVERSITY [JP/JP]; 宮城県仙台市青葉区片平二丁目1番1号 2-1-1, Katahira, Aoba-ku, Sendai-shi, Miyagi 9808577, JP
株式会社レナサイエンス RENASCIENCE CO., LTD. [JP/JP]; 東京都中央区日本橋本町2丁目3-6 協同ビル401号室 Kyodo Building 401, 3-6, Nihonbashihoncho 2-chome, Chuo-ku, Tokyo 1030023, JP
Inventors:
宮田 敏男 MIYATA, Toshio; JP
呉 繁夫 KURE, Shigeo; JP
栗山 進一 KURIYAMA, Shinichi; JP
佐藤 寛記 SATO, Hiroki; JP
Agent:
特許業務法人三枝国際特許事務所 SAEGUSA & PARTNERS; 大阪府大阪市中央区道修町1-7-1 北浜TNKビル Kitahama TNK Building, 1-7-1, Doshomachi, Chuo-ku, Osaka-shi, Osaka 5410045, JP
Priority Data:
2016-04049202.03.2016JP
Title (EN) COMPOSITION USED TO IMPROVE SYMPTOMS OF AUTISM SPECTRUM DISORDER, AND METHOD USING SAME FOR IMPROVING SYMPTOMS OF AUTISM SPECTRUM DISORDER
(FR) COMPOSITION UTILISÉE POUR AMÉLIORER LES SYMPTÔMES DU TROUBLE DU SPECTRE AUTISTIQUE ET PROCÉDÉ L'UTILISANT POUR AMÉLIORER LES SYMPTÔMES DU TROUBLE DU SPECTRE AUTISTIQUE
(JA) 自閉スペクトラム症の症状改善に使用される組成物、及びそれを用いた自閉スペクトラム症の症状改善方法
Abstract:
(EN) The present invention provides a composition that is effective in improving the symptoms of autism spectrum disorder. The composition is characterized in containing, as an active ingredient, at least one type of pyridoxamine compound selected from the group consisting of pyridoxamine and a pharmaceutically acceptable salt thereof. The composition can also be used in combination with at least one type of thiamine compound selected from the group consisting of thiamine, a derivative thereof, and a pharmaceutically acceptable salt thereof.
(FR) La présente invention concerne une composition efficace pour améliorer les symptômes du trouble du spectre autistique. La composition est caractérisée en ce qu'elle contient, comme principe actif, au moins un type de composé pyridoxamine sélectionné dans le groupe constitué de pyridoxamine et de son sel de qualité pharmaceutique. La composition peut également être utilisée en combinaison avec au moins un type de composé thiamine sélectionné dans le groupe constitué de thiamine, de son dérivé et de son sel de qualité pharmaceutique.
(JA) 本発明は、自閉スペクトラム症の症状を改善するために有効な組成物を提供する。当該組成物は、ピリドキサミン、及びその薬学的に許容される塩からなる群から選択される少なくとも一種のピリドキサミン化合物を有効成分とすることを特徴とする。当該組成物はチアミン、その誘導体、及びそれらの薬学的に許容される塩からなる群から選択される少なくとも一種のチアミン化合物と組み合わせて使用することもできる。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)